Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 157

1.

The immunogenicity of seasonal and pandemic influenza vaccination in autoimmune inflammatory rheumatic patients-a 6-month follow-up prospective study.

Lakota K, Perdan-Pirkmajer K, Sodin-Šemrl S, Čučnik S, Šubelj V, Prosenc K, Mrak Poljšak K, Tomšič M, Ambrožič A, Praprotnik S.

Clin Rheumatol. 2019 Feb 14. doi: 10.1007/s10067-019-04439-y. [Epub ahead of print]

PMID:
30761436
2.

IgA vasculitis in adults: few certainties and many uncertainties.

Hočevar A, Tomšič M, Rotar Ž.

Ann Rheum Dis. 2019 Jan 5. pii: annrheumdis-2018-214907. doi: 10.1136/annrheumdis-2018-214907. [Epub ahead of print] No abstract available.

PMID:
30612119
4.

Smoking and response to rituximab in rheumatoid arthritis: results from an international European collaboration.

Chatzidionysiou K, Lukina G, Gabay C, Hetland ML, Hauge EM, Pavelka K, Nordström D, Canhão H, Tomsic M, Rotar Z, Lie E, Kvien TK, van Vollenhoven RF, Saevarsdottir S.

Scand J Rheumatol. 2019 Jan;48(1):17-23. doi: 10.1080/03009742.2018.1466363. Epub 2018 Sep 27.

PMID:
30260261
5.

Autoantibodies against dsDNA measured with nonradioactive Farr assay-an alternative for routine laboratories.

Lakota K, Švec T, Kveder T, Sodin-Šemrl S, Žigon P, Ambrožič A, Ogrič M, Markez S, Božič B, Tomšič M, Čučnik S.

Clin Rheumatol. 2019 Feb;38(2):353-359. doi: 10.1007/s10067-018-4271-3. Epub 2018 Sep 10.

PMID:
30203316
6.

Utility of serological biomarkers for giant cell arteritis in a large cohort of treatment-naïve patients.

Burja B, Feichtinger J, Lakota K, Thallinger GG, Sodin-Semrl S, Kuret T, Rotar Ž, Ješe R, Žigon P, Čučnik S, Mali P, Praprotnik S, Tomšič M, Hočevar A.

Clin Rheumatol. 2019 Feb;38(2):317-329. doi: 10.1007/s10067-018-4240-x. Epub 2018 Aug 24.

PMID:
30143961
7.

Added value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome: lessons learned from year-long routine measurements.

Žigon P, Podovšovnik A, Ambrožič A, Tomšič M, Hočevar A, Gašperšič N, Rotar Ž, Praprotnik S, Šemrl SS, Čučnik S.

Clin Rheumatol. 2019 Feb;38(2):371-378. doi: 10.1007/s10067-018-4251-7. Epub 2018 Aug 11.

PMID:
30099654
8.

Stroke and antiphospholipid syndrome-antiphospholipid antibodies are a risk factor for an ischemic cerebrovascular event.

Gašperšič N, Zaletel M, Kobal J, Žigon P, Čučnik S, Šemrl SS, Tomšič M, Ambrožič A.

Clin Rheumatol. 2019 Feb;38(2):379-384. doi: 10.1007/s10067-018-4247-3. Epub 2018 Aug 7.

PMID:
30088114
9.

Does leflunomide have a role in giant cell arteritis? An open-label study.

Hočevar A, Ješe R, Rotar Ž, Tomšič M.

Clin Rheumatol. 2019 Feb;38(2):291-296. doi: 10.1007/s10067-018-4232-x. Epub 2018 Aug 6.

PMID:
30084049
10.

MicroRNA expression in the affected skin of adult patients with IgA vasculitis.

Hočevar A, Tomšič M, Pižem J, Bolha L, Sodin-Šemrl S, Glavač D.

Clin Rheumatol. 2019 Feb;38(2):339-345. doi: 10.1007/s10067-018-4250-8. Epub 2018 Aug 6.

PMID:
30084048
11.

Antiphospholipid antibodies in adult IgA vasculitis: observational study.

Hočevar A, Rotar Ž, Žigon P, Čučnik S, Ostrovršnik J, Tomšič M.

Clin Rheumatol. 2019 Feb;38(2):347-351. doi: 10.1007/s10067-018-4248-2. Epub 2018 Aug 2.

PMID:
30073461
12.

The incidence of idiopathic inflammatory myopathies in the adult Slovenian population.

Ostrovršnik J, Hočevar A, Rotar Ž, Krošel M, Čučnik S, Jurčić V, Tomšič M.

Clin Rheumatol. 2019 Feb;38(2):279-283. doi: 10.1007/s10067-018-4237-5. Epub 2018 Aug 2.

PMID:
30073460
13.

The incidence rate and the early management of rheumatoid arthritis in Slovenia.

Ješe R, Perdan-Pirkmajer K, Hočevar A, Rotar Ž, Markez S, Pavič-Nikolič M, Tomšič M.

Clin Rheumatol. 2019 Feb;38(2):273-278. doi: 10.1007/s10067-018-4235-7. Epub 2018 Aug 2.

PMID:
30073459
14.

Insight into inflammatory cell and cytokine profiles in adult IgA vasculitis.

Kuret T, Lakota K, Žigon P, Ogrič M, Sodin-Šemrl S, Čučnik S, Tomšič M, Hočevar A.

Clin Rheumatol. 2019 Feb;38(2):331-338. doi: 10.1007/s10067-018-4234-8. Epub 2018 Aug 2.

PMID:
30073458
15.

Gene and miRNA expression in giant cell arteritis-a concise systematic review of significantly modified studies.

Kuret T, Burja B, Feichtinger J, Thallinger GG, Frank-Bertoncelj M, Lakota K, Žigon P, Sodin-Semrl S, Čučnik S, Tomšič M, Hočevar A.

Clin Rheumatol. 2019 Feb;38(2):307-316. doi: 10.1007/s10067-018-4231-y. Epub 2018 Aug 1.

PMID:
30069799
16.

The incidence of giant cell arteritis in Slovenia.

Pucelj NP, Hočevar A, Ješe R, Rotar Ž, Hawlina M, Fakin A, Pižem J, Tomšič M.

Clin Rheumatol. 2019 Feb;38(2):285-290. doi: 10.1007/s10067-018-4236-6. Epub 2018 Jul 30.

PMID:
30062445
17.

Analysis of Drug Effects on Primary Human Coronary Artery Endothelial Cells Activated by Serum Amyloid A.

Lakota K, Hrušovar D, Ogrič M, Mrak-Poljšak K, Čučnik S, Tomšič M, Božič B, Žigon P, Sodin-Semrl S.

Mediators Inflamm. 2018 Feb 13;2018:8237209. doi: 10.1155/2018/8237209. eCollection 2018.

18.

Naturally occurring antibodies against serum amyloid A reduce IL-6 release from peripheral blood mononuclear cells.

Kuret T, Lakota K, Mali P, Čučnik S, Praprotnik S, Tomšič M, Sodin-Semrl S.

PLoS One. 2018 Apr 4;13(4):e0195346. doi: 10.1371/journal.pone.0195346. eCollection 2018.

19.
20.

Secukinumab for the maintenance of glucocorticoid-free remission in a patient with giant cell arteritis and psoriatic arthritis.

Rotar Ž, Tomšic M, Hocevar A.

Rheumatology (Oxford). 2018 May 1;57(5):934-936. doi: 10.1093/rheumatology/kex507. No abstract available.

PMID:
29394408

Supplemental Content

Loading ...
Support Center